Use of transurethral alprostadil (MUSE) (prostaglandin E1) for glans tumescence in a patient with penile prosthesis

International Journal of Impotence Research

Volumn 12, Issue 3, 2000, Pages 195-196

  Chew, K K ^a   Stuckey, B G A ^a  

^a PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Alprostadil; Glans penis; MUSE; Penile prosthesis; Prostaglandin E1; Tumescence

Indexed keywords

PROSTAGLANDIN E1; TESTOSTERONE;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; ERECTILE DYSFUNCTION; HUMAN; IMPLANT; MALE; MALE SEXUAL DYSFUNCTION; PENIS ERECTION; PENIS PROSTHESIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033835638     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900523     Document Type: Article

References (6)

1. Evaluation of patients and partners 1 to 4 years after penile prosthetic surgery
2. Sexual performance and satisfaction with penile prostheses in impotence of various etiologies
3. Patient-partner satisfaction with semirigid penile prostheses for Peyronie's disease: A 5-year followup study
4. Intracavernosal prostaglandin E1 and penile implant
5. Functional and radiologic evidence of vascular communication between the spongiosal and cavernosal compartments of the penis
6. Penile venous drainage in erectile dysfunction. Anatomical, radiological and functional considerations